Axogen Inc Stock Analysis

AXGN Stock  USD 12.54  0.93  8.01%   
Axogen Inc is undervalued with Real Value of 15.6 and Target Price of 24.43. The main objective of Axogen stock analysis is to determine its intrinsic value, which is an estimate of what Axogen Inc is worth, separate from its market price. There are two main types of Axogen's stock analysis: fundamental analysis and technical analysis.
The Axogen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Axogen is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Axogen Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Axogen Stock Analysis Notes

About 86.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.16. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994. AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 428 people. For more info on Axogen Inc please contact Michael Dale at 386 462 6800 or go to https://www.axogeninc.com.

Axogen Inc Investment Alerts

Axogen Inc generated a negative expected return over the last 90 days
Axogen Inc has high historical volatility and very poor performance
The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 144.29 M.
Over 86.0% of the company shares are held by institutions such as insurance companies
Latest headline from gurufocus.com: Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

Axogen Inc Upcoming and Recent Events

Earnings reports are used by Axogen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
12th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Axogen Largest EPS Surprises

Earnings surprises can significantly impact Axogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-02
2024-03-31-0.07-0.060.0114 
2020-02-24
2019-12-31-0.09-0.1-0.0111 
2018-02-28
2017-12-31-0.08-0.070.0112 
View All Earnings Estimates

Axogen Environmental, Social, and Governance (ESG) Scores

Axogen's ESG score is a quantitative measure that evaluates Axogen's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Axogen's operations that may have significant financial implications and affect Axogen's stock price as well as guide investors towards more socially responsible investments.

Axogen Stock Institutional Investors

Shares
Wasatch Advisors Lp2025-03-31
774.6 K
Dafna Capital Management Llc2025-03-31
680.8 K
Balyasny Asset Management Llc2025-03-31
680.2 K
Marshall Wace Asset Management Ltd2025-03-31
668.3 K
Deutsche Bank Ag2025-03-31
591.3 K
Silvercrest Asset Management Group Llc2025-03-31
580.2 K
D. E. Shaw & Co Lp2025-03-31
562.4 K
Armistice Capital, Llc2025-03-31
538.3 K
Parkman Healthcare Partners Llc2025-03-31
536.8 K
First Light Asset Management, Llc2025-03-31
4.5 M
Blackrock Inc2025-03-31
3.6 M
Note, although Axogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Axogen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 571.12 M.

Axogen Profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.05)(0.05)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.05)(0.05)
Return On Equity(0.10)(0.10)

Management Efficiency

As of the 23rd of July 2025, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to grow to -0.02. At this time, Axogen's Asset Turnover is very stable compared to the past year. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 2.35  1.50 
Tangible Book Value Per Share 2.22  1.45 
Enterprise Value Over EBITDA 126.75  133.09 
Price Book Value Ratio 7.02  12.77 
Enterprise Value Multiple 126.75  133.09 
Price Fair Value 7.02  12.77 
Enterprise Value770.5 M809 M
At Axogen Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Operating Margin
(0.03)
Profit Margin
(0.04)
Beta
1.037
Return On Assets
(0)
Return On Equity
(0.07)

Technical Drivers

As of the 23rd of July, Axogen shows the Standard Deviation of 4.12, risk adjusted performance of (0.04), and Mean Deviation of 2.58. Axogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Axogen Inc Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Axogen Inc price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Axogen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Axogen Outstanding Bonds

Axogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Axogen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Axogen bonds can be classified according to their maturity, which is the date when Axogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Axogen Predictive Daily Indicators

Axogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Axogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Axogen Corporate Filings

8K
20th of June 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
11th of June 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
23rd of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
16th of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
15th of May 2025
Other Reports
ViewVerify
8K
8th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
2nd of May 2025
Other Reports
ViewVerify
30th of April 2025
Other Reports
ViewVerify

Axogen Forecast Models

Axogen's time-series forecasting models are one of many Axogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Axogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Axogen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Axogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Axogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Axogen. By using and applying Axogen Stock analysis, traders can create a robust methodology for identifying Axogen entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.05)(0.06)
Operating Profit Margin(0.02)(0.02)
Net Loss(0.05)(0.06)
Gross Profit Margin 0.76  0.46 

Current Axogen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Axogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Axogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.43Strong Buy7Odds
Axogen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Axogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Axogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Axogen Inc, talking to its executives and customers, or listening to Axogen conference calls.
Axogen Analyst Advice Details

Axogen Stock Analysis Indicators

Axogen Inc stock analysis indicators help investors evaluate how Axogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Axogen shares will generate the highest return on investment. By understating and applying Axogen stock analysis, traders can identify Axogen position entry and exit signals to maximize returns.
Begin Period Cash Flow37 M
Long Term Debt47.5 M
Common Stock Shares Outstanding44.3 M
Total Stockholder Equity103.9 M
Total Cashflows From Investing Activities-10.3 M
Property Plant And Equipment Net98.9 M
Cash And Short Term Investments33.5 M
Cash27.6 M
Accounts PayableM
Net Debt41.1 M
50 Day M A11.0046
Total Current Liabilities30.6 M
Other Operating Expenses190.6 M
Non Current Assets Total104.5 M
Forward Price Earnings42.9185
Stock Based Compensation15.9 M
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.16)
Revenue Per Share
4.347
Quarterly Revenue Growth
0.174
Return On Assets
(0)
Return On Equity
(0.07)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.